Dr Durnell has been with Gentel for over a year where he served as the vice president of commercial operations. In his new role, Dr Durnell will be responsible for all aspects of Gentel’s commercial business, including manufacturing and corporate development.
Dr Clutter will report to Dr Durnell and has responsibility for sales, marketing and product commercialization. Prior to joining Gentel, Dr Clutter has been in sales, marketing and business development for PerkinElmer, Invitrogen, Roche, Celera, PanVera, Asterand and NimbleGen.
Dr Durnell said: “Dan brings Gentel a wealth of scientific knowledge and expertise in product commercialization that directly relates to the pending launch of several new biomarker products and a low cost multiplex scanner. We are very pleased to have Dan as a member of our executive team at Gentel.”